Additionally, numerous survival analyses were conducted and the findings showed that high HMGN1 expression levels were responsible for poor prognosis of ACC, ESCA, CESC, KIRC, KICH, LIHC, LGG, PCPG, SARC, MESO, PRAD, and UVM patients. The gene discussed is HMGN1; the disease is adrenal cortex carcinoma.